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Introduction {#sec001}
============

Schizophrenia (SZ) is a common, chronic, and complex psychiatric disorder that includes delusions and hallucinations, reduced interest and drive, altered emotional reactivity, and disorganized behavior \[[@pone.0125925.ref001]\]. SZ affects 1.0% of the worldwide population \[[@pone.0125925.ref002]\]. Family studies, including twin and adoption studies, provide evidence that SZ is predominantly a genetic disorder, and heritability estimates for SZ range from 60% to 80% \[[@pone.0125925.ref003]‒[@pone.0125925.ref005]\]. Traditionally, SZ genetic research focused on identifying linkage regions, candidate genes, and polymorphisms. Data indicated susceptibility genes contributed to SZ \[[@pone.0125925.ref006]‒[@pone.0125925.ref009]\]. Some results suggest that multiple, individual mutations that alter genes in neurotransmitter pathways contribute to SZ \[[@pone.0125925.ref010]‒[@pone.0125925.ref012]\].

Glutamate (Glu) is the primary excitatory neurotransmitter involved in various neural processes, including neuronal development, synaptic plasticity, and neuronal toxicity in the brain system \[[@pone.0125925.ref013]\]. In the late 1980s, the Glu hypofunction model of SZ was first suggested, and was based upon the observation that phencyclidine, ketamine, and similarly-acting psychotomimetic compounds induced their unique behavioral effects by blocking neurotransmission at N-methyl-D-aspartate-type glutamate receptors (NMDAR) \[[@pone.0125925.ref010]\]. Moreover, the glutamate system consists of interconnecting pathways of the cerebral cortex and limbic system, which are brain regions implicated in SZ pathophysiology \[[@pone.0125925.ref011]\]. As glutamate receptors, NMDARs are ligand- and voltage-gated ion channels that play crucial roles in excitatory synaptic transmission, plasticity, and excitoxicity. They are composed of an N-methyl-D-aspartate-type glutamate (NMDA) receptor NR1 subunit (GRIN1) and one of the four NMDA receptor NR2 subunits (GRIN2A-D) \[[@pone.0125925.ref014]‒[@pone.0125925.ref016]\]. Among the proposed mechanisms, disturbances in NMDAR-mediated neuronal transmission offer a logical hypothesis for SZ development.

The NR2B subunit is encoded by the NMDA receptor 2B subunit gene (*GRIN2B*; MIN_138252), which is located at chromosome 12p12 and consists of 13 exons. Moreover, variations in *GRIN2B* have been linked to SZ \[[@pone.0125925.ref017],[@pone.0125925.ref018]\]. The NMDA subunit NR2B, encoded by *GRIN2B*, has been implicated in cases of mental retardation \[[@pone.0125925.ref019]\]. Many recent studies have focused on insertion/deletion polymorphisms and explored potential associations between *GRIN2B* and SZ. Excessive rare missense *GRIN2B* mutations have also been reported in people with both SZ and autism \[[@pone.0125925.ref020]\]. However, other studies had inconsistent results \[[@pone.0125925.ref018],[@pone.0125925.ref020] **‒** [@pone.0125925.ref024]\]. SZ is highly heterogeneous in both clinical expression and genotype, and it is believed that variations in genotype are related to different clinical subtypes. In the present study, we performed a case--control analysis to investigate the potential association between *GRIN2B* SNPs and SZ symptoms in the Han Chinese population.

Materials and Methods {#sec002}
=====================

Subjects {#sec003}
--------

The Ethical Committee of the Second Affiliated Hospital of Xinxiang Medical University (China) approved the study protocol. Written informed consent was obtained from all participants after the objectives and procedures of the study were fully explained.

The patient population was recruited from inpatients at the Second Affiliated Hospital of Xinxiang Medical University from March 2005 to December 2008. The population consisted of 528 SZ patients (264 males and 264 females; mean age: 27.32 ± 8.03 years old) and 528 healthy controls (264 males and 264 females; mean age: 27.73 ± 8.01 years old). Patients were unrelated Han Chinese born and living in the North Henan province, and all of their biological grandparents were of Han Chinese ancestry. Consensus diagnoses were made by at least two experienced psychiatrists according to the Diagnostic and Statistical Manual of Mental Disorders-Fourth Edition IV (DSM-IV) (1994) diagnostic criteria for SZ. Only paranoid SZ patients were selected. Individuals with a history of severe medical complications, organic brain disease, other major psychiatric disorders, or substance dependence were excluded.

The age of SZ onset was the age at first manifestation of positive symptoms \[[@pone.0125925.ref025]\], and was derived from the Comprehensive Assessment of Symptoms and History (CASH) \[[@pone.0125925.ref026]\]. A "family mental health history" was defined as at least one first- or second-degree relative of the proband who met the DSM-IV criteria for SZ or schizoaffective disorder, and was obtained from the patient or a family member during the initial interview. The raters involved in this study were trained psychiatrists experienced in the administration of psychopathological tests such as the CASH and Positive and Negative Symptom Scale (PANSS). To ensure inter-rater consistency, all participating psychiatrists underwent training every 6 months wherein diagnoses and test results were compared using videotaped demonstration interviews. Agreement among the raters was high for the DSM-IV, CASH, and PANSS, with kappa values ranging from 0.762 to 0.843 and intraclass correlation coefficients (r values) ranging from 0.827 to 0.933.

Two hundred and twenty-nine patients (116 males and 113 females, mean age 27.53 ± 6.01 years, part of the total sample of 528 patients) were evaluated for psychotic syndromes using the PANSS \[[@pone.0125925.ref027]\] when not taking any antipsychotic medications. Raters were trained to administer the PANSS using the Structured Clinical Interview for the PANSS and achieved an inter-rater reliability of 0.80 or greater. Five factors were derived from PANSS \[[@pone.0125925.ref028]\]: positive (items P1, P3, P6, G6), negative (N1, N2, N3, N4, N6, G7, G13, G16, P5), expression/anxiety (G1, G2, G3, G4, G6, G12), cognition (P2, N5, N7, G5, G10, G11, G15), and excitement/hostility (P4, P7, G8, G14).

Healthy controls were recruited volunteers from communities and colleges within the same region and matched to the patient group for gender ratio (1:1 for both groups), age (F = 0.699, *p* = 0.403), and Han ethnicity, and with simple non-structured interviews performed by psychiatrists. Any individual with a personal or family history of mental or neurological diseases was excluded. All participants were unrelated Han Chinese who were born and living in the North Henan province. Their biological grandparents were of Han Chinese ancestry.

Peripheral blood samples from each subject were collected into vacutainer tubes containing the anticoagulant ethylene-diaminetetracetic acid. Genomic DNA was extracted from leukocytes using the RelaxGene Blood DNA System (Tiangen Biotech, Beijing, China).

SNP selection {#sec004}
-------------

In this study, *GRIN2B* SNPs were selected for study according to the following criteria: (1) All SNPs covering the genomic region chr12: 13605448−14022988 were included in functional analyses using the FASTSNP online service ([http://fastsnp.ibms.sinica.edu.tw](http://fastsnp.ibms.sinica.edu.tw/).) \[[@pone.0125925.ref029]\]. Only those SNPs with highly ranked risk and a minor allele frequency (MAF) ≥0.05 in the Chinese Beijing population according to the HapMap database were selected; (2) Tag SNPs were chosen based on the aggressive tagging algorithm (Carlson et al., 2004) (*r* ^*2*^ *≥* 0.80, MAF ≥0.05) using genotype data from the HapMap database as implemented in Haploview v4.1 (<http://www.broad.mit.edu/mpg/haploview/>) \[[@pone.0125925.ref030]\]; and, (3) All SNPs selected using these two criteria were assessed using Illumina design scores, and all SNPs with scores below 0.6 were excluded.

Genotyping {#sec005}
----------

Genotyping was performed using Illumina GoldenGate assays on a BeadStation 500G Genotyping System (Illumina, Inc., San Diego, CA, USA). DNA samples (250 ng) were genotyped according to the Illumina protocol. DNA samples from cases and controls were randomly sorted, including 96 duplicated DNA samples for genotyping quality control. Genotype calls were made using the Genotyping module of the BeadStudio 2.0 software (Illumina, Inc.). All genotype data were examined for cluster separation using Illumina quality scores generated by the software. Poorly performing SNPs were excluded, designated by a GenTrain score \<0.4 or a cluster separation score \<0.6. SNPs were further excluded from controls not in Hardy--Weinberg equilibrium (HWE). As a genotyping quality control, four SNPs were genotyped in duplicate (100 samples) by DNA sequencing.

Statistical analyses {#sec006}
--------------------

Genotypes and alleles were compared between patients and controls using the Golden Helix SVS7.2 program with 10,000 random permutations (Golden Helix, Inc. Bozeman, MT, USA; <http://www.goldenhelix.com/>). HWE was also calculated using this software. The standardized measure of linkage disequilibrium (LD), coefficients (D′), haplotype frequency, haplotype block, and haplotype association was assessed using the Haploview V4.1 program \[[@pone.0125925.ref030]\].

Single-SNP analyses for individual genotyping data were performed using Pearson's chi-square tests on allele and genotype counts. Correlations between alleles and SZ were performed using Armitage trend tests. Odds ratio (OR) and 95% confidence intervals (95% CI) were calculated to evaluate the effect of different alleles and haplotypes. HWE was assessed using chi-square tests with one degree of freedom. Haplotype frequencies were estimated using the expectation maximization (EM) algorithm. To evaluate interactions between genes and sex, global test for interaction was performed. *p*\<0.05 was considered statistically significant for tests with expected HWE. Power analyses were performed using the Genetic Power Calculator for this study \[[@pone.0125925.ref031]\]. Genotyping data were analyzed using Structure 2.3 (<http://pritchardlab.stanford.edu/structure_software/release_versions/v2.3.4/html/structure.html>) to generate population stratification assignments for all individuals using the Markov chain Monte Carlo (MCMC) algorithm \[[@pone.0125925.ref032]\].

Genotype differences between SZ patients and healthy controls were compared using chi-square tests (1 df). Associations between age-at-onset subgroups and different genotype carriers were tested using one-way analysis of variance (ANOVA) tests (SPSS version 13.0, SPSS, Inc. Chicago, IL, USA). Differences between *GRIN2B* genotypes in the SZ group and scores of five factors from the PANSS were examined using ANOVA with age, age at onset and illness duration as covariables. Fisher's least significant difference (LSD) tests were used for pair-wise comparisons of the three genotypes following one-way ANOVA tests. The Bonferroni correction for multiple pair-wise comparisons was conducted for the (X × phenotype) interaction to reduce the probability of false positives, as the probability of at least one chance rejection of the null hypothesis (the product of α and the number of possible comparisons) was *p* = 0.25. The corrected α′ (*p* = 0.01) is α (*p* = 0.05) divided by the number of possible comparisons. Bonferroni corrections for multiple tests were performed to exclude type I errors.

Results {#sec007}
=======

To reveal allelic variants of the *GRIN2B* gene that are associated with SZ, we analyzed the allele and genotype frequencies of thirty-four common SNPs in 528 SZ patients and 528 controls of Han Chinese descent. For power test, we set the parameters as follows: SNP site = rs2098469, high risk allele frequency (A) = 0.16, prevalence = 0.1 (prevalence of SZ), genotype relative risk Aa = 1.12, genotype relative risk AA = 2.96 (1.12 and 2.96 were used the online software to analyzed. <http://bioinfo.iconcologia.net/snpstats/start.ht>), number of cases = 528. For a power above 80%, 392 cases are needed according to Genetic Power Calculator, so for genotype analyses, the sample size (n = 528) had sufficient power (0.70--0.80) to detect effects. Power analyses revealed that the total sample size (n = 1056) had a power of 0.86 to detect a small effect (r = 0.1--0.23), and a power of 1.00 to detect both medium (r = 0.24--0.36) and large (r\>0.37) effects on genotype distributions. For allele frequency, the sample size (n = 2112) had the power (0.91--1.00) to detect small, medium, and large effects. The sampling success rate for all subjects and SNPs was 99.75%, and the genotype concordance between the BeadStation 500G Genotyping System and DNA sequencing was 99.25%. Evaluation of population structure using 10,000 iterations for the burn-in period and 10,000 repeats after burn-in revealed no evidence of population stratification in the control group (*K* = 1, *p* = 1).

None of the genotype distributions of these thirty-four SNPs significantly deviated from HWM. There was a significant association in allele at rs2098469 and rs12319804 between SZ and controls (*p* = 0.025 and 0.035, respectively, [Table 1](#pone.0125925.t001){ref-type="table"}). Significant associations were found in the genotypes between SZ and controls at rs2098469, rs12820037, and rs7298664 (*p* = 0.014, 0.003, and 4.27×10^-8^, respectively, [Table 1](#pone.0125925.t001){ref-type="table"}). After applying the Bonferroni correction, rs7298664 still had significant genotype associations with SZ (*p* = 1.71×10^-7^). In addition, significant differences were found in the genotypes of males (rs7298664) and females (rs2098469, rs12820037, and rs1806201) between SZ and controls when the two groups were subdivided by gender (*p* = 8.43×10^-18^, 0.036, 9.5×10^-5^, and 0.018, respectively; [S1 Table](#pone.0125925.s003){ref-type="supplementary-material"}). After applying the Bonferroni correction, rs7298664 and rs12820037 still had significant genotype associations with SZ in male and female respectively (*p* = 3.37×10^-17^ and 3.7×10^-4^, respectively; [S1 Table](#pone.0125925.s003){ref-type="supplementary-material"}).

10.1371/journal.pone.0125925.t001

###### Genotype and allele frequencies of thirty-four SNPs in the *GRIN2B* gene in SZ patients and controls.

![](pone.0125925.t001){#pone.0125925.t001g}

  SNP\#   dbSNP ID     Allele(D/d)[^a^](#t001fn002){ref-type="table-fn"}   Patients   Controls   *p*-value   *Corrected p*-value                                                                                                                                                                                                                                               
  ------- ------------ --------------------------------------------------- ---------- ---------- ----------- --------------------- ----- ------- ----- -------- ----- ----- ----- ------- ----------------------------------------------------------------- ------------------------------------------------ ----------------------------------------------------------------- -------
  1       rs1805502    A/G                                                 527        0.973      337         169                   21    0.200   528   0.230    348   156   24    0.193   0.639                                                             0.685                                            1                                                                 1
  2       rs1805476    A/C                                                 524        0.880      321         179                   24    0.217   527   0.657    334   169   24    0.206   0.764                                                             0547                                             1                                                                 1
  3       rs890        A/C                                                 528        0.065      286         216                   26    0.254   528   0.536    312   191   25    0.228   0.261                                                             0.169                                            1                                                                 1
  4       rs1805247    A/G                                                 527        0.939      339         167                   21    0.198   528   0.253    347   157   24    0.194   0.740                                                             0.809                                            1                                                                 1
  5       rs1806191    G/A                                                 527        0.706      510         17                    0     0.016   528   0.740    513   15    0     0.014   0.715                                                             0.717                                            1                                                                 1
  6       rs1806201    G/A                                                 526        0.001      114         310                   102   0.489   525   0.398    133   272   120   0.488   0.964                                                             0.067                                            1                                                                 1
  7       rs1805522    G/A                                                 527        0.686      347         163                   17    0.187   528   0.303    361   147   20    0.177   0.510                                                             0.558                                            1                                                                 1
  8       rs1805482    G/A                                                 527        0.723      511         16                    0     0.015   527   0.774    514   13    0     0.012   0.572                                                             0.574                                            1                                                                 1
  9       rs10845849   A/C                                                 527        0.390      300         200                   27    0.241   528   0.962    326   178   24    0.214   0281                                                              0.139                                            1                                                                 1
  10      rs12319804   A/G                                                 528        0.811      334         173                   21    0.204   527   0.561    363   151   13    0.168   0.101                                                             **0.035[\*](#t001fn001){ref-type="table-fn"}**   1                                                                 1
  11      rs10845851   A/G                                                 528        0438       172         251                   105   0.437   528   0.392    168   251   109   0.444   0.940                                                             0725                                             1                                                                 1
  12      rs12582848   C/A                                                 527        0.878      147         261                   119   0.473   527   0.589    144   257   126   0.483   0.877                                                             0.662                                            1                                                                 1
  13      rs7952915    C/G                                                 527        0.306      239         224                   64    0.334   528   0.998    217   243   68    0.359   0376                                                              0.228                                            1                                                                 1
  14      rs2041986    G/A                                                 528        0.883      242         232                   54    0.322   528   0.512    242   226   60    0.328   0.821                                                             0.780                                            1                                                                 1
  15      rs11055665   G/A                                                 527        0.542      220         236                   71    0.359   527   0.746    209   243   75    0.373   0.781                                                             0.497                                            1                                                                 1
  16      rs7314376    G/A                                                 528        0.895      322         180                   26    0.220   528   0.163    320   189   19    0.215   0.518                                                             0.791                                            1                                                                 1
  17      rs7297101    A/C                                                 527        0.601      165         265                   97    0.435   528   0.064    190   236   102   0.417   0.168                                                             0.382                                            1                                                                 1
  18      rs2098469    A/C                                                 528        0.199      372         147                   9     0.156   528   0.139    349   154   25    0.193   **0.014 [\*](#t001fn001){ref-type="table-fn"}**                   **0.025[\*](#t001fn001){ref-type="table-fn"}**   0.448                                                             0.997
  19      rs10459061   C/A                                                 528        0.245      185         244                   99    0.419   528   0.179    193   240   95    0.407   0.867                                                             0.595                                            1                                                                 1
  20      rs219876     G/ A                                                527        0.773      433         90                    4     0.093   528   0.164    447   75    6     0.082   0.370                                                             0.389                                            1                                                                 1
  21      rs7295850    C/G                                                 527        0.543      298         200                   29    0.245   528   0.770    302   193   33    0.245   0.815                                                             0.979                                            1                                                                 1
  22      rs219905     C/A                                                 528        0.392      144         254                   130   0.487   527   0.308    153   251   123   0.472   0.785                                                             0.484                                            1                                                                 1
  23      rs219913     A/G                                                 528        0.086      470         54                    4     0.059   528   0.495    466   61    1     0.060   0.325                                                             0.926                                            1                                                                 1
  24      rs1558908    G/A                                                 526        0.689      179         253                   96    0.421   527   0.0208   197   229   101   0.409   0.335                                                             0.560                                            1                                                                 1
  25      rs12829455   G/A                                                 527        0.042      465         58                    5     0.064   528   0.409    462   65    1     0.063   0.214                                                             0.929                                            1                                                                 1
  26      rs17221245   A/G                                                 525        0.919      309         187                   29    0.233   524   0.497    301   196   27    0.239   0.824                                                             0.778                                            1                                                                 1
  27      rs12820037   A/G                                                 526        0.000      416         92                    18    0.122   525   0242     421   101   3     0.102   **0.003 [\*](#t001fn001){ref-type="table-fn"}**                   0.150                                            0.094                                                             1
  28      rs219936     A/G                                                 523        0.223      141         250                   137   0.496   528   0.223    138   250   140   0.498   0.968                                                             0.794                                            1                                                                 1
  29      rs11055697   A/G                                                 527        0.950      171         259                   97    0.430   526   0.783    173   260   93    0.424   0.952                                                             0.786                                            1                                                                 1
  30      rs12824372   A/G                                                 528        0.832      261         219                   48    0.298   525   0.644    265   215   48    0.295   0.966                                                             0.848                                            1                                                                 1
  31      rs7298664    A/G                                                 527        0.532      341         163                   23    0.198   528   0.000    385   88    55    0.188   **4.27×10** ^**--8**^ **[\*](#t001fn001){ref-type="table-fn"}**   0.529                                            **1.71×10** ^**--7**^ **[\*](#t001fn001){ref-type="table-fn"}**   1
  32      rs10505778   G/A                                                 528        0.625      166         265                   97    0.435   528   0.958    164   260   104   0.443   0.859                                                             0.693                                            1                                                                 1
  33      rs1421108    A/G                                                 524        0.024      175         264                   65    0.391   527   0.098    177   260   70    0.394   0.896                                                             0.868                                            1                                                                 1
  34      rs12581502   G/A                                                 528        0.527      252         221                   55    0.313   528   0.313    260   214   54    0.305   0.883                                                             0.671                                            1                                                                 1

**\*** *p*\<0.05;

a Major/minor allele, major and minor alleles are denoted by D and d, respectively;

b Number of samples that are well genotyped.

To further analyze the haplotype structure in our sample, we evaluated pair-wise LD of thirty-four SNPs in the SZ patient and control group using the standardized D′ and r^2^ values. The position of these SNPs in *GRIN2B*, the LD structure, and the D′ values for all variants are shown in [Fig 1](#pone.0125925.g001){ref-type="fig"}. The LD maps for SZ patient and control samples were presented in [S1 Fig](#pone.0125925.s001){ref-type="supplementary-material"} and [S2 Fig](#pone.0125925.s002){ref-type="supplementary-material"} respectively. Thirty-four SNPs formed seven LD blocks. Within these blocks, twenty-seven haplotypes were formed, but only three haplotypes, CGA, CC, and AAGA in block 3, 4, and 5, had significantly differed between SZ and controls (*p* = 0.037, 0.032, and 0.034, respectively). [Table 2](#pone.0125925.t002){ref-type="table"} shows the three significantly associated haplotypes.

![Haplotype block structure of the *GRIN2B* gene in both SZ patients and health controls.\
Thirty-four SNPs formed seven LD blocks. The index association SNP is represented by a diamond. The color of the remaining SNPs (circles) indicates LD with the index SNP based on pairwise r^2^ values from our data.](pone.0125925.g001){#pone.0125925.g001}

10.1371/journal.pone.0125925.t002

###### Frequencies of three schizophrenia associated haplotypes in SZ patients and controls.

![](pone.0125925.t002){#pone.0125925.t002g}

  Block                                                    Haplotype   Haplotype frequencies   χ^2^    *p*-value   
  -------------------------------------------------------- ----------- ----------------------- ------- ----------- -------
  3 (rs10845849- rs12319804-rs10845851)                    CGA         0.168                   0.204   4.324       0.037
  4 (rs12582848-rs7952915)                                 CC          0.158                   0.194   4.582       0.032
  5 (rs2041986-rs11055665-rs7314376-rs7297101-rs2098469)   AAGAC       0.189                   0.154   4.492       0.034

To investigate the association between *GRIN2B* variations and symptoms, 228 SZ patients with complete PANSS scores were selected. As shown in [Table 3](#pone.0125925.t003){ref-type="table"}, three SNPs positively associated with SZ, and also significantly associated with total PANSS and other five factor scores. Other SNPs from these samples were not found to have these associations. Furthermore, there were significant associations between rs2098469 and total PANSS and five factor subscores with age, age at onset, and illness duration as covariables (*p* = 0.000, [S2 Table](#pone.0125925.s004){ref-type="supplementary-material"}). Two SNPs, rs12319804 and rs12820037, were significantly associated with positive and cognition factor subscores (*p* = 0.000, 0.000 and *p* = 0.025, 0.003, respectively).

10.1371/journal.pone.0125925.t003

###### Association analyses between five factors of PANSS and three *GRIN2B* SNPs in patients with SZ.

![](pone.0125925.t003){#pone.0125925.t003g}

  SNP          Genotype                                                 Total PANSS                                              Positive                                                 Negative                                                Depression/anxiety                                      Cognition                                               Excitement/hostility
  ------------ -------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- ------------------------------------------------------- -------------------------------------------------------
  rs2098469    AA(168)                                                  90.80±22.02[^**\***^](#t003fn001){ref-type="table-fn"}   14.80±3.34[^**\***^](#t003fn001){ref-type="table-fn"}    25.62±8.36[^**\***^](#t003fn001){ref-type="table-fn"}   15.06±5.18[^**\***^](#t003fn001){ref-type="table-fn"}   14.64±5.70[^**\***^](#t003fn001){ref-type="table-fn"}   12.41±4.80[^**\***^](#t003fn001){ref-type="table-fn"}
  AC(57)       95.54±20.77[^**\***^](#t003fn001){ref-type="table-fn"}   15.53±3.19[^**\***^](#t003fn001){ref-type="table-fn"}    27.04±8.84[^**\***^](#t003fn001){ref-type="table-fn"}    15.66±4.75[^**\***^](#t003fn001){ref-type="table-fn"}   15.51±5.80[^**\***^](#t003fn001){ref-type="table-fn"}   13.16±4.39[^**\***^](#t003fn001){ref-type="table-fn"}   
  CC(3)        75.33±15.94[^**\***^](#t003fn001){ref-type="table-fn"}   ---                                                      75.33±15.94[^**\***^](#t003fn001){ref-type="table-fn"}   ---                                                     ---                                                     ---                                                     
  rs12820037   AA(175)                                                  92.68±21.89[^**a**^](#t003fn003){ref-type="table-fn"}    15.07±3.24                                               26.43±8.77[^**a**^](#t003fn003){ref-type="table-fn"}    15.07±5.12[^**b**^](#t003fn004){ref-type="table-fn"}    14.97±5.85[^**b**^](#t003fn004){ref-type="table-fn"}    12.73±4.78[^**a**^](#t003fn003){ref-type="table-fn"}
  AG(44)       88.03±22.57[^**c**^](#t003fn005){ref-type="table-fn"}    14.60±3.61                                               23.79±7.67                                               15.09±5.07[^**b**^](#t003fn004){ref-type="table-fn"}    14.53±5.56[^**b**^](#t003fn004){ref-type="table-fn"}    12.13±4.82                                              
  GG(9)        92.90±13.17                                              14.89±2.80                                               25.54±6.16[^**a**^](#t003fn003){ref-type="table-fn"}     17.15±3.58                                              13.14±2.81                                              12.35±2.50                                              
  rs7298664    AA(144)                                                  91.09±20.57[^**b**^](#t003fn004){ref-type="table-fn"}    14.85±2.95[^**b**^](#t003fn004){ref-type="table-fn"}     25.88±8.01                                              15.34±5.04[^**\***^](#t003fn001){ref-type="table-fn"}   14.49±5.41[^**\***^](#t003fn001){ref-type="table-fn"}   12.12±4.84[^**b**^](#t003fn004){ref-type="table-fn"}
  AG(76)       92.36±23.22[^**b**^](#t003fn004){ref-type="table-fn"}    14.87±3.43[^**b**^](#t003fn004){ref-type="table-fn"}     26.08±9.55                                               14.29±4.51[^**\***^](#t003fn001){ref-type="table-fn"}   15.20±6.09[^**\***^](#t003fn001){ref-type="table-fn"}   13.44±4.27[^**c**^](#t003fn005){ref-type="table-fn"}    
  GG(8)        99.27±27.02                                              17.82±±5.54                                              24.93±7.95                                               19.42±7.15[^**\***^](#t003fn001){ref-type="table-fn"}   16.80±6.64[^**\***^](#t003fn001){ref-type="table-fn"}   13.43±5.34                                              

**\*** *p*\<0.05, compared with each genotype, LSD tests

"---" indicates the genotype was not determined

**a** *p*\<0.05, compared with AG genotype, LSD tests

**b** *p*\<0.05, compared with GG genotype, LSD tests

**c** *p*\<0.05, compared with AA genotype, LSD tests

Discussion {#sec008}
==========

This study aimed to investigate the *GRIN2B* mutations associated with SZ and psychotic symptoms in the Han Chinese population. Significant differences were observed in genotype frequencies of three SNPs, rs2098469, rs12820037, and rs7298664, between patients and controls. In addition, the allele frequencies of the rs12319804 and rs2098469 SNPs were significantly associated with SZ in this population. Furthermore, the rs7298664 genotype association remained after Bonferroni correction. In addition, the rs2098469 genotype and allele frequencies, and the 12820037 allele frequencies were nominally associated with SZ. Our results found novel variants can influence SZ risk in the Han Chinese population.

Previous studies revealed that dysfunction of the glutamatergic signaling system was a major mechanism in SZ pathogenesis, and genes encoding NMDA receptors are obvious candidates in numerous association studies of SZ \[[@pone.0125925.ref033]‒[@pone.0125925.ref037]\]. More studies have focused on the association of *GRIN2B* with SZ. The original studies reported that some *GRIN2B* SNPs were significantly associated with SZ \[[@pone.0125925.ref020],[@pone.0125925.ref022],[@pone.0125925.ref023],[@pone.0125925.ref038]‒[@pone.0125925.ref040]\]. In addition, the rs1019385 SNP was associated with SZ in several studies and meta-analyses \[[@pone.0125925.ref022],[@pone.0125925.ref034],[@pone.0125925.ref035],[@pone.0125925.ref038]\]. However, other studies found no such associations \[[@pone.0125925.ref018],[@pone.0125925.ref021],[@pone.0125925.ref024]\]. Our study could not validate the positive association of rs1019385; however, novel variants of *GRIN2B*, including rs2098469, rs12820037, and rs7298664 had significant association in genotype frequency with SZ. We also found significant association with SZ when the two groups were subdivided by gender. Moreover, our results are consistent with previous studies that reported no association of rs1805247, rs1806191, rs1806201, rs3026160, rs1805522, rs1805482, and rs35025065 with SZ \[[@pone.0125925.ref018],[@pone.0125925.ref041]\]. The present study revealed significant association in alleles between SZ and controls at rs12319804 and rs2098469, which differs from data in previous studies \[[@pone.0125925.ref038],[@pone.0125925.ref040]\]. Further association analyses of haplotypes consisting of thirty-four SNPs at the *GRIN2B* gene with SZ were performed. Three haplotypes at *GRIN2B* significantly associated with SZ. In previous studies, better memory performance was observed in the absence of the T-T haplotype at *GRIN2B* rs220599 and rs12828473 \[[@pone.0125925.ref042],[@pone.0125925.ref043]\]. Our results were inconsistent with these previous studies \[[@pone.0125925.ref018],[@pone.0125925.ref022],[@pone.0125925.ref023]\]. There are several explanations for these disparate findings. First, the small sample size and high phenotypic heterogeneity likely contributed to low statistical power, such as the conclusions of Martucci *et al*. \[[@pone.0125925.ref022]\]. Therefore, by including only paranoid SZ patients and enlarging the sample size (528 SZ patients and 528 controls), we potentially improved the power to detect disease associations. In addition, more markers were tested in this study compared to previous reports. Second, differences in population ethnicity and stratification may lead to the high heterogeneity of samples. All of our subjects were living in the North Henan province and belonged to the same population group based on structure analyses. Third, because SZ is a complex genetic disease and genome-wide association studies have revealed multiple susceptibility genes that contribute to SZ pathogenesis \[[@pone.0125925.ref008],[@pone.0125925.ref009]\], each gene might exert weak-to-moderate effects.

SZ is characterized by several symptom domains: positive symptoms, negative symptoms, disorganization of thoughts and behaviors, and cognitive deficits \[[@pone.0125925.ref044],[@pone.0125925.ref045]\]. Several studies have explored the associated between *GRIN2B* and cognitive deficit symptoms \[[@pone.0125925.ref021],[@pone.0125925.ref042],[@pone.0125925.ref043]\], differential language lateralization \[[@pone.0125925.ref046]\], anti-psychotic-induced movement disorders \[[@pone.0125925.ref047]\], and clozapine-induced obsessive-compulsive symptoms \[[@pone.0125925.ref048]\]. However, there are few studies regarding positive and negative symptoms of SZ and *GRIN2B*. Genetic enhancement of *GRIN2B* may improve learning and memory in mice, and NMDA dysfunction has been related to cognitive impairment associated with SZ \[[@pone.0125925.ref049],[@pone.0125925.ref050]\]. Several studies have revealed the association between *GRIN2B* and clinically-manifested cognitive deficit symptoms, including memory performance \[[@pone.0125925.ref042],[@pone.0125925.ref043]\]. Currently, neurocognitive dysfunction is a core feature of SZ and recognized in more SZ patients \[[@pone.0125925.ref051]\]. Therefore, we investigated this feature in our SZ patients using five factors of PANSS. In our study, three SNPs, rs2098469, rs12820037, and rs7298664, were associated with positive, negative, expression/anxiety, and cognition factor PANSS subscores in SZ patients. These differ with former data regarding rs12828473 and rs220599 \[[@pone.0125925.ref042],[@pone.0125925.ref043]\]. The differences may be due to unknown population stratification \[[@pone.0125925.ref018]\], limited sample size \[[@pone.0125925.ref022]\], incomplete information, or sample heterogeneity \[[@pone.0125925.ref023]\]. Thus, all results revealed that genetic variations of *GRIN2B* influence symptom traits in SZ. Moreover, rs2098469, rs12820037, and rs7298664 were associated with cognition factor subscores in SZ patients with age, age at onset, and illness duration as covariables. Therefore, our study provided novel evidence for the association of *GRIN2B* with cognition deficit symptoms.

SZ is influenced by glutamatergic neurotransmission and other neurotransmitter networks, including serotonin and dopamine systems. Additionally, we had previously found an association between *SLC6A4* in the serotonin system and SZ \[[@pone.0125925.ref052]\]. Hence, further studies should examine the interaction of different neurotransmission systems, and how candidate genes affect glutamatergic and related signaling pathways and alter SZ symptoms.

This study had some limitations. First, our sample size may not be large enough for complete PANSS scores. Second, we only selected paranoid SZ patients, not included other subtypes (catatonic, collapse, residual and undifferentiated). Third, this study was limited by a lack of independent validation. Therefore, the further research will need improving in this aspects.

Conclusion {#sec009}
==========

In summary, our study provides novel data suggesting an association between *GRIN2B* and SZ susceptibility and symptoms. Other studies in different ethnic populations, particularly in patients with defined SZ phenotypes, are required to confirm the role of *GRIN2B* variants in paranoid SZ.
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###### Haplotype block structure of the *GRIN2B* gene in SZ patients.

Thirty-four SNPs formed seven LD blocks. The index association SNP is represented by a diamond. The color of the remaining SNPs (circles) indicates LD with the index SNP based on pairwise r^2^ values from our data.

(TIF)

###### 

Click here for additional data file.

###### Haplotype block structure of the *GRIN2B* gene in health controls.

Thirty-four SNPs formed six LD blocks. The index association SNP is represented by a diamond. The color of the remaining SNPs (circles) indicates LD with the index SNP based on pairwise r^2^ values from our data.

(TIF)

###### 

Click here for additional data file.

###### Genotypic and allelic frequencies of thirty-four SNPs from the chi-square test in female and male samples.

(PDF)

###### 

Click here for additional data file.

###### Association analyses between five factors of PANSS and three *GRIN2B* SNPs with three covariables in patients with SZ.

(PDF)

###### 

Click here for additional data file.
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